Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05084430
Title Study of Pembrolizumab and M032 (NSC 733972)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications

glioblastoma

gliosarcoma

high grade glioma

anaplastic astrocytoma

Therapies

M032 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.